Biomarck Pharmaceuticals presentation at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021
Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers: Milken Institute COVID-19 Treatment and Vaccine Tracker | Artis Ventures
Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides to develop and license products targeted at difficult to treat diseases.